With the recent postponement of the World Trade Organization (WTO) Ministerial Conference in Geneva, uncertainty swirls around the fate of the WTO TRIPS Waiver on intellectual property of COVID-19 medical tools, which was to have been central to the ministerial discussions and the culmination of many months of mobilisation and support for the proposal first brought by India and South Africa in October 2020.
